Kevin Bielamowicz - Concepedia

Author

Kevin Bielamowicz

Also Known As

K Bielamowicz, K. Bielamowicz, K.J. Bielamowicz, Kalra, Mamta, Kevin J. Bielamowicz, Kevin Bielamowicz, Kevin J Bielamowicz, Kevin J. Bielamowicz, Laura K. Metrock

166

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine University of Arkansas for Medical Sciences Children's Cancer Center Texas Children's Hospital Arkansas Children's Hospital

About

Kevin Bielamowicz is an author at Baylor College of Medicine specializing in medicine, radiation oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Cell Biology	3	3	747
3	Engineering	1	1	13
4	Anatomy	1	1	13
5	Cellular Therapies	1	1	61

Kevin Bielamowicz

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, JAMA Oncology	2017	805
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Journal of Clinical Investigation ImmunologyImmune RegulationImmunoeditingImmunologic MechanismTancar T Cells	2016	656
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma Kevin Bielamowicz, Kristen Fousek, Tiara T. Byrd, Neuro-Oncology	2017	407
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma Laura Donovan, Alberto Delaidelli, Sujith K. Joseph, Nature Medicine Neuro-oncologyCar T CellsCerebrospinal FluidLocoregional DeliverySurgery	2020	228
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer Tiara T. Byrd, Kristen Fousek, Antonella Pignata, Cancer Research	2017	154
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Christopher L. Moertel, Angela C. Hirbe, Hans Shuhaiber, Journal of Clinical Oncology	2024	62
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Journal for ImmunoTherapy of Cancer Cell TherapyImmunologyHigh-grade GliomasImmunotherapyGlioma	2015	61
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study Ayse B. Ercan, Melyssa Aronson, Nicholas R. Fernandez, The Lancet Oncology Family MedicineBiological LandscapeGenetic DisorderClinical GeneticsMedicine	2024	49
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma Kathleen Danielle Aldrich, Vincent E. Horne, Kevin Bielamowicz, Journal of Neuro-Oncology Growth Hormone DeficiencyThyroid DiseasePediatricsAdrenal InsufficiencyThyroid Disorders	2021	38
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium Anirban Das, Nicholas R. Fernandez, Adrian Levine, Cancer Discovery	2023	37

Page 1